Latest Ratios: P/E Ratio 233.2x · EV/EBITDA 16.4x · ROE 1.1%. (2014–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $516M | $441M | $510M | $671M | $846M | $1.1B | $1.0B | $801M | $509M | $416M | $261M |
| Enterprise Value | $1.0B | $974M | $995M | $1.1B | $1.2B | $1.4B | $1.2B | $993M | $655M | $508M | $310M |
| P/E Ratio → | 233.20 | 212.14 | — | 133.20 | 44.20 | 54.33 | 58.89 | 115.84 | 115.32 | 147.89 | 95.96 |
| P/S Ratio | 4.26 | 3.64 | 4.40 | 5.95 | 8.66 | 12.14 | 13.43 | 13.16 | 10.47 | 11.15 | 10.35 |
| P/B Ratio | 1.13 | 1.03 | 1.07 | 1.31 | 1.70 | 2.38 | 2.36 | 2.27 | 1.22 | 1.11 | 1.07 |
| P/FCF | 9.14 | 7.81 | 14.89 | 15.83 | 16.95 | 22.38 | 24.57 | 28.61 | 25.62 | 19.83 | 19.53 |
| P/OCF | 9.14 | 7.81 | 8.66 | 10.94 | 14.03 | 19.52 | 21.01 | 24.75 | 20.84 | 18.81 | 17.46 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 8.04 | 8.60 | 9.57 | 12.20 | 15.09 | 16.21 | 16.33 | 13.47 | 13.59 | 12.31 |
| EV / EBITDA | 16.43 | 15.26 | 15.59 | 16.48 | 17.77 | 21.31 | 22.96 | 23.98 | 13.49 | 13.59 | 12.31 |
| EV / EBIT | 51.74 | 24.86 | 48.49 | 41.85 | 35.12 | 41.16 | 43.95 | 52.00 | 71.56 | 68.71 | 80.16 |
| EV / FCF | — | 17.26 | 29.07 | 25.47 | 23.88 | 27.82 | 29.66 | 35.49 | 32.95 | 24.17 | 23.23 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.7% | 8.7% | 80.3% | 81.6% | 83.0% | 83.3% | 82.0% | 79.9% | 79.6% | 76.8% | 81.2% |
| Operating Margin | 16.7% | 16.7% | 17.4% | 22.2% | 34.7% | 36.3% | 36.9% | 30.7% | 27.6% | 19.8% | 15.4% |
| Net Profit Margin | 4.2% | 4.2% | -2.7% | 6.8% | 22.5% | 24.8% | 25.2% | 13.8% | 9.1% | 9.4% | 10.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.1% | 1.1% | -0.6% | 1.5% | 4.6% | 5.0% | 4.9% | 2.2% | 1.1% | 1.1% | 1.5% |
| ROA | 0.5% | 0.5% | -0.3% | 0.8% | 2.7% | 3.2% | 3.1% | 1.7% | 1.1% | 1.1% | 1.4% |
| ROIC | 1.6% | 1.6% | 1.6% | 2.1% | 3.2% | 3.6% | 3.5% | 2.5% | 2.0% | 1.5% | 1.3% |
| ROCE | 2.8% | 2.8% | 2.4% | 2.8% | 4.3% | 4.8% | 4.8% | 4.0% | 3.5% | 2.3% | 2.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.25 | 1.25 | 1.03 | 0.80 | 0.72 | 0.58 | 0.50 | 0.55 | 0.35 | 0.25 | 0.21 |
| Debt / EBITDA | 8.40 | 8.40 | 7.68 | 6.29 | 5.32 | 4.20 | 3.99 | 4.69 | 3.04 | 2.50 | 2.02 |
| Net Debt / Equity | — | 1.24 | 1.02 | 0.80 | 0.70 | 0.58 | 0.49 | 0.55 | 0.35 | 0.24 | 0.20 |
| Net Debt / EBITDA | 8.35 | 8.35 | 7.61 | 6.24 | 5.16 | 4.16 | 3.94 | 4.65 | 3.00 | 2.44 | 1.96 |
| Debt / FCF | — | 9.44 | 14.18 | 9.64 | 6.93 | 5.44 | 5.09 | 6.88 | 7.33 | 4.34 | 3.70 |
| Interest Coverage | 1.15 | 1.15 | 0.87 | 1.45 | 2.86 | 3.15 | 3.24 | 2.05 | 1.45 | 1.87 | 3.28 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.17 | 0.17 | 0.25 | 5.74 | 4.39 | 1.98 | 0.77 | 1.66 | 0.70 | 7.72 | 3.49 |
| Quick Ratio | 0.17 | 0.17 | 0.25 | 5.74 | 4.39 | 1.98 | 0.77 | 1.66 | 0.72 | 7.79 | 3.56 |
| Cash Ratio | 0.01 | 0.01 | 0.02 | 0.29 | 0.74 | 0.10 | 0.06 | 0.08 | 0.04 | 0.53 | 0.44 |
| Asset Turnover | — | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 | 0.11 | 0.11 | 0.11 | 0.10 | 0.10 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 11.1% | 12.2% | 10.1% | 7.2% | 5.3% | 3.9% | 3.7% | 4.0% | 5.8% | 5.9% | 6.8% |
| Payout Ratio | 1051.9% | 1051.9% | — | 623.0% | 202.0% | 188.5% | 199.4% | 381.4% | 667.2% | 696.1% | 653.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.4% | 0.5% | — | 0.8% | 2.3% | 1.8% | 1.7% | 0.9% | 0.9% | 0.7% | 1.0% |
| FCF Yield | 10.9% | 12.8% | 6.7% | 6.3% | 5.9% | 4.5% | 4.1% | 3.5% | 3.9% | 5.0% | 5.1% |
| Buyback Yield | 0.3% | 0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 11.4% | 12.6% | 10.1% | 7.2% | 5.3% | 3.9% | 3.7% | 4.0% | 5.8% | 5.9% | 6.8% |
| Shares Outstanding | — | $27M | $27M | $25M | $24M | $23M | $22M | $19M | $18M | $15M | $11M |
Dividend sustainability and leverage
As reported in financial statements, CHCT's P/E ratio of 236.82 and the absence of stable P/FFO metrics suggest that the market is struggling to price the company's earnings, likely due to the extreme volatility in FFO per share observed over the last ten quarters.
The lack of a consistent P/FFO multiple makes traditional REIT valuation difficult, implying that investors are currently pricing the stock based on dividend yield rather than core earnings power. This valuation profile warrants caution, as the high dividend yield of 10.9% may be a market signal of perceived risk rather than an attractive entry point.
Based on reported figures, the FFO payout ratio frequently exceeds 100%, such as the 103.5% recorded in 2026Q1, indicating that the company is distributing more cash than its operations generate, which raises significant concerns regarding the long-term viability of the current dividend policy.
When a REIT consistently pays out more than its FFO, it must rely on external capital or debt to fund the shortfall, which is inherently unsustainable. Investors should monitor whether management chooses to rebase the dividend to align with actual AFFO, as the current payout trajectory appears to be eroding the company's internal capital base.
According to recent SEC filings, the debt-to-equity ratio has trended upward from 0.80 in 2023Q4 to 1.25 by 2025Q4, suggesting that the company is increasingly relying on debt to support its portfolio expansion despite the volatility in its core earnings performance.
The combination of rising leverage and declining interest coverage, which dropped to 1.38x in 2026Q1, suggests that the company's balance sheet is becoming increasingly sensitive to interest rate fluctuations. This trend may limit the firm's ability to pursue future accretive acquisitions without further diluting existing shareholders through equity issuance.
As indicated by the provided financial data, the most commonly misapplied metric for CHCT is the standard P/E ratio, which fails to account for the massive non-cash depreciation charges inherent in the REIT business model, thereby obscuring the company's true cash-generating capacity.
Using P/E for a REIT like CHCT is fundamentally misleading because it treats depreciation as a cash expense, which significantly distorts the valuation. Analysts should instead focus on P/AFFO, which adjusts for recurring capital expenditures and provides a more accurate reflection of the cash available for distribution to shareholders.
Includes 30+ ratios · 12 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CHCT stock.
Community Healthcare Trust Incorporated's current P/E ratio is 233.2x. The historical average is 95.7x. This places it at the 100th percentile of its historical range.
Community Healthcare Trust Incorporated's current EV/EBITDA is 16.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.9x.
Community Healthcare Trust Incorporated's return on equity (ROE) is 1.1%. The historical average is 1.8%.
Based on historical data, Community Healthcare Trust Incorporated is trading at a P/E of 233.2x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Community Healthcare Trust Incorporated's current dividend yield is 11.07% with a payout ratio of 1051.9%.
Community Healthcare Trust Incorporated has 8.7% gross margin and 16.7% operating margin. Operating margin between 10-20% is typical for established companies.
Community Healthcare Trust Incorporated's Debt/EBITDA ratio is 8.4x, indicating high leverage. A ratio above 4x may signal elevated financial risk.